Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials
Author:
Publisher
Elsevier BV
Subject
Biotechnology
Reference29 articles.
1. Cancer statistics, 2003;Jemal;CA Cancer J. Clin.,2003
2. Long-term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group Experience;Bennett;Cancer,1997
3. Effect of complete remission on survival of patients with acute myelogenous leukemia receiving first salvage therapy;Vey;Blood,1999
4. Update in childhood acute myeloid leukemia: recent developments in the molecular basis of disease and novel therapies;Clark;Curr. Opin. Hematol.,2003
5. Is modulation of multidrug resistance a viable strategy for acute myeloid leukemia?;Larson;Leukemia,2003
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hosts and Heterologous Expression Strategies of Recombinant Toxins for Therapeutic Purposes;Toxins;2023-12-13
2. In vivo solid tumor targeting with recombinant VEGF-diphtheria immunotoxin;IRAN J BASIC MED SCI;2022
3. Expression of full and fragment-B of diphtheria toxin genes inEscherichia colifor generating of recombinant diphtheria vaccines;Clinical and Experimental Vaccine Research;2022
4. In Silico Design of Fusion Toxin DT389GCSF and a Comparative Study;Current Computer-Aided Drug Design;2020-06-02
5. Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN);Expert Opinion on Biological Therapy;2019-12-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3